Pelthos Therapeutics to Present at the Piper Sandler 37th Annual Healthcare Conference

Core Viewpoint - Pelthos Therapeutics Inc. is actively engaging with investors and the healthcare community through participation in the Piper Sandler 37th Annual Healthcare Conference, highlighting its commitment to addressing unmet patient needs with innovative therapeutic products [1][2]. Company Overview - Pelthos Therapeutics is a biopharmaceutical company focused on commercializing innovative, safe, and effective therapeutic products for patients facing unmet treatment burdens [3]. - The company's lead product, ZELSUVMI™ (berdazimer) topical gel, 10.3%, received approval from the U.S. Food and Drug Administration in 2024 for the treatment of molluscum contagiosum [3]. Event Participation - CEO Scott Plesha will participate in a fireside chat at the Piper Sandler 37th Annual Healthcare Conference on December 4, 2025, at 9:30 a.m. Eastern Time [1]. - Institutional investors can schedule one-on-one meetings with Mr. Plesha through their Piper Sandler representatives [2]. - A live webcast of the fireside chat will be available on the company's website approximately two hours after the event [2].